[1]
O. Chertkova and K. Hoshtynar, “Pharmacist’s readiness to manage risks of drug-related problems associated with escitalopram therapy (according to survey data)”, USMYJ, vol. 157, no. 3, pp. 155-160, Sep. 2025.